New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

DXSE

Xtrackers MSCI Europe Health Care UCITS ETF

The DXSE Exchange Traded Fund (ETF) is provided by Xtrackers by DWS. It is built to track an index: MSCI Europe Health Care 20/35 Capped Index. The DXSE ETF provides physical exposure, so by buying it you actually own parts of all the 39 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

€230.12
N/A
Data as of 07/23/26
1D price range
N/A
52W price range
€191.06€241.24
YTD Perf.
+2.38%
YTD Flows
Annualized volatility
Fund AuM
€336M
Share class AuM
€336M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
LU0292103222
TER
0.17%
Inception date
6/26/2007
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 23, 2026
-6%-4%-2%0%2%4%6%8%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
96.09%
Consumer Cyclicals
3.02%
Other
0.76%
Latest DXSE news

FAQ about DXSE

DXSE is a Passive ETF. This ETF provides exposure to Large and Mid-Cap European Health Care Equities.
DXSE tracks the MSCI Europe Health Care 20/35 Capped GTR Index - EUR, through a full replication replication method.
DXSE carries a total expense ratio (TER) of 0.17%, indicating the annual cost for holding the fund.
DXSE was introduced to the market on June 26, 2007. It trades on Italy, among other exchanges
Xtrackers MSCI Europe Health Care UCITS ETF, DXSE, is provided by Xtrackers by DWS. Learn more about Xtrackers by DWS here.
DXSE oversees €336M in assets as of July 23, 2026.
DXSE follows a capitalizing, meaning it reinvests income within the fund.
As of June 30, 2026, DXSE has significant geographic allocations in Switzerland, United Kingdom and Denmark.
As of June 30, 2026, DXSE focuses largely on Healthcare and Consumer Cyclicals.
As of June 30, 2026, DXSE holds 39 positions in its portfolio, with 87.33% of assets concentrated in its top 15 holdings.
As of June 30, 2026, DXSE top three holdings include Roche Holding AG, AstraZeneca PLC and Novartis AG.
The base currency of DXSE is EUR.
Data as of 06/30/26
Roche Holding AG
15.83%
AstraZeneca PLC
15.40%
Novartis AG
15.37%
Novo Nordisk A/S
8.33%
GSK Plc
5.72%
Sanofi
5.06%
EssilorLuxottica SA
3.02%
argenx SE
2.99%
Bayer AG
2.78%
Lonza Group AG
2.52%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight